Nizoral (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. Without ergosterol, the membrane becomes defective, leading to increased permeability and cell death, thereby clearing the infection.

The exact dosing regimen for Nizoral is determined by the prescribing healthcare professional based on the specific indication, severity of infection, patient age, and skin area involved. Typically, the product is applied once or twice daily to the affected area, but the prescriber provides the final instructions.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers weigh the potential benefits against any possible risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their clinician.

To request Nizoral, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Nizoral belongs to the azole class, which inhibits ergosterol synthesis. Compared with allylamine agents such as terbinafine, azoles have a broader spectrum against yeasts and dermatophytes but may cause more local irritation. Choice of therapy depends on the specific fungus, infection site, patient tolerance and clinician preference.

Store Nizoral at room temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Clean and gently dry the affected skin area before use. Apply a thin layer of the cream or lotion to the lesion and a small margin of surrounding skin, usually once or twice daily as directed by the prescriber. Wash hands after application unless treating the hands themselves.

While most reactions are mild, serious adverse events can include severe contact dermatitis, systemic absorption leading to liver enzyme changes (rare with topical use), allergic reactions such as hives or swelling, and, in extremely rare cases, Stevens‑Johnson syndrome. Prompt medical attention is required if any severe symptoms develop.

Nizoral should be avoided in individuals with a known hypersensitivity to ketoconazole or any other azole antifungal. It is also contraindicated on severely damaged or broken skin, and caution is advised in patients with pre‑existing liver disease when systemic absorption is possible.